Disc Medicine (IRON) Competitors $59.65 -0.01 (-0.02%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$59.75 +0.10 (+0.17%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRON vs. ROIV, GRFS, RVMD, RYTM, LEGN, RGC, RNA, AXSM, ABVX, and NUVLShould you be buying Disc Medicine stock or one of its competitors? The main competitors of Disc Medicine include Roivant Sciences (ROIV), Grifols (GRFS), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Regencell Bioscience (RGC), Avidity Biosciences (RNA), Axsome Therapeutics (AXSM), Abivax (ABVX), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Disc Medicine vs. Its Competitors Roivant Sciences Grifols Revolution Medicines Rhythm Pharmaceuticals Legend Biotech Regencell Bioscience Avidity Biosciences Axsome Therapeutics Abivax Nuvalent Disc Medicine (NASDAQ:IRON) and Roivant Sciences (NASDAQ:ROIV) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Which has better earnings & valuation, IRON or ROIV? Disc Medicine has higher earnings, but lower revenue than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Disc Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$109.36M-$4.47-13.34Roivant Sciences$29.05M280.44-$171.98M-$0.70-17.04 Which has more volatility and risk, IRON or ROIV? Disc Medicine has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Does the media refer more to IRON or ROIV? In the previous week, Disc Medicine had 3 more articles in the media than Roivant Sciences. MarketBeat recorded 9 mentions for Disc Medicine and 6 mentions for Roivant Sciences. Roivant Sciences' average media sentiment score of 1.65 beat Disc Medicine's score of 1.43 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Disc Medicine 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts rate IRON or ROIV? Disc Medicine currently has a consensus price target of $98.30, suggesting a potential upside of 64.79%. Roivant Sciences has a consensus price target of $16.50, suggesting a potential upside of 38.31%. Given Disc Medicine's higher possible upside, research analysts plainly believe Disc Medicine is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.25 Is IRON or ROIV more profitable? Disc Medicine has a net margin of 0.00% compared to Roivant Sciences' net margin of -2,111.79%. Roivant Sciences' return on equity of -15.90% beat Disc Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -26.60% -24.58% Roivant Sciences -2,111.79%-15.90%-14.95% Do insiders & institutionals believe in IRON or ROIV? 83.7% of Disc Medicine shares are held by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are held by institutional investors. 3.6% of Disc Medicine shares are held by company insiders. Comparatively, 10.8% of Roivant Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryRoivant Sciences beats Disc Medicine on 9 of the 16 factors compared between the two stocks. Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRON vs. The Competition Export to ExcelMetricDisc MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.07B$3.08B$5.71B$9.76BDividend YieldN/A2.28%6.66%4.48%P/E Ratio-13.3420.7883.6526.57Price / SalesN/A393.33548.40112.35Price / CashN/A43.5325.6628.92Price / Book4.029.7811.366.08Net Income-$109.36M-$54.01M$3.27B$265.84M7 Day Performance-0.22%-0.71%0.01%-0.10%1 Month Performance1.15%8.53%8.36%5.86%1 Year Performance17.38%7.03%56.70%18.11% Disc Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRONDisc Medicine3.5924 of 5 stars$59.650.0%$98.30+64.8%+17.4%$2.07BN/A-13.3430News CoveragePositive NewsROIVRoivant Sciences3.1633 of 5 stars$11.64-2.3%$16.50+41.8%-2.5%$8.14B$29.05M-16.63860News CoveragePositive NewsGRFSGrifols3.5559 of 5 stars$9.82-3.3%$10.30+4.9%+6.7%$6.99B$7.81B8.3923,822News CoveragePositive NewsRVMDRevolution Medicines4.3469 of 5 stars$35.67-3.6%$69.92+96.0%-10.9%$6.92BN/A-7.93250News CoveragePositive NewsRYTMRhythm Pharmaceuticals3.4469 of 5 stars$99.20-3.9%$101.57+2.4%+118.1%$6.86B$130.13M-32.96140Positive NewsLEGNLegend Biotech3.6521 of 5 stars$34.60-2.7%$73.00+111.0%-39.7%$6.53B$627.24M-39.322,609RGCRegencell Bioscience0.2421 of 5 stars$12.28-4.1%N/AN/A$6.33BN/A0.0010Positive NewsGap DownRNAAvidity Biosciences3.0525 of 5 stars$45.27-2.3%$67.00+48.0%+5.9%$5.96B$10.90M-12.72190Positive NewsAXSMAxsome Therapeutics4.7473 of 5 stars$116.31-1.9%$178.00+53.0%+36.5%$5.91B$385.69M-22.94380Positive NewsABVXAbivax2.4019 of 5 stars$77.46+0.2%$92.33+19.2%+537.5%$5.84BN/A0.0061News CoveragePositive NewsNUVLNuvalent3.3404 of 5 stars$74.05-2.7%$118.91+60.6%-10.0%$5.49BN/A-15.1140News CoveragePositive News Related Companies and Tools Related Companies Roivant Sciences Alternatives Grifols Alternatives Revolution Medicines Alternatives Rhythm Pharmaceuticals Alternatives Legend Biotech Alternatives Regencell Bioscience Alternatives Avidity Biosciences Alternatives Axsome Therapeutics Alternatives Abivax Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRON) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSell this, buy thatI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredHave You Seen This? Trump Schedules 'Stock Market Reset' For Sept. 30Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRON Stock Alerts